Delivery Order SPE2DX22D0010-SPE2D825FHT56
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,240.67 to AmerisourceBergen Drug Corp for the supply of Nucynta Tabs 100mg, a pain management pharmaceutical product. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. The delivery order is scheduled for completion by July 31, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nucynta 75 mg tablets (100 count) valued at $1,432.38 under a firm fixed price contract. The award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This delivery order, awarded on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division, provides for the supply of Nucynta Tabs 50mg, a prescription pain management medication, to support federal medical procurement needs. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on a firm fixed-price basis with a ceiling value of $4,442.48 and an ultimate completion date of July 24, 2025. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,347.68 for 100 tablets of Nucynta 50 mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. Nucynta is a pain management pharmaceutical used across military and federal healthcare systems. This...
- The Defense Logistics Agency awarded a $2,208.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, with an ultimate completion date of August 20, 2025. The award, issued on August 19, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,802.98 firm fixed price delivery order is for the supply of Nucynta Tablets 75mg, a prescription pain medication. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHT56Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $13,932.13 for Nucynta Tabs 75mg, a pain management pharmaceutical product. This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value and extends through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 8/19/25 |